C. Brink
发表
L. Walch,
C. Brink,
X. Norel,
2001,
Therapie.
J. Michel,
H. Hlawaty,
C. Labat,
2007,
PloS one.
Takao Shimizu,
Jilly F. Evans,
Takehiko Yokomizo,
2004,
Pharmacological Reviews.
C. Labat,
A. Serraf,
V. de Montpréville,
1995,
The Annals of thoracic surgery.
J. Michel,
L. Louedec,
M. Bäck,
2009,
American journal of physiology. Heart and circulatory physiology.
J. Bara,
V. de Montpréville,
C. Brink,
2001,
Mediators of inflammation.
M. Yeadon,
J. Bara,
V. de Montpréville,
2000,
Mediators of inflammation.
C. Brink,
X. Norel,
2004,
Pharmacology & therapeutics.
Jilly F. Evans,
J. Drazen,
S. Dahlén,
2003,
Pharmacological Reviews.
L. Walch,
C. Brink,
X. Norel,
2004,
British journal of pharmacology.
J. Douglas,
C. Brink,
P. Duncan,
2005,
Agents and Actions.
Takao Shimizu,
Charles N. Serhan,
G. Enrico Rovati,
2006,
Pharmacological Reviews.
C. Brink,
2007,
TheScientificWorldJournal.
P. Braquet,
J. Mencia-Huerta,
C. Brink,
1991,
Pulmonary pharmacology.
C. Labat,
J. Benveniste,
C. Brink,
1988,
European journal of pharmacology.
C. Labat,
J. Benveniste,
C. Brink,
1988,
Progress in clinical and biological research.
C. Labat,
J. Benveniste,
C. Brink,
1983,
British journal of pharmacology.
C. Brink,
2003,
Advances in experimental medicine and biology.
C. Labat,
R. Müller-Peddinghaus,
C. Brink,
1994,
The Journal of pharmacology and experimental therapeutics.
J. Calvet,
C. Brink,
S. Delamanche,
1999,
Human & experimental toxicology.
C. Labat,
V. de Montpréville,
C. Brink,
1996,
Life sciences.
J. Douglas,
C. Brink,
P. Duncan,
1982
.
C. Labat,
J. Benveniste,
C. Brink,
1986,
The Journal of pharmacology and experimental therapeutics.
F. Ledda,
J. Benveniste,
C. Brink,
1989,
British journal of pharmacology.
C. Labat,
C. Brink,
J. Cerrina,
2015,
The American review of respiratory disease.
C. Labat,
J. Benveniste,
C. Brink,
1985,
The Journal of pharmacology and experimental therapeutics.
L. Walch,
C. Brink,
X. Norel,
2000,
American journal of respiratory and critical care medicine.
C. Brink,
J. Gascard,
1999,
Advances in experimental medicine and biology.
C. Brink,
J. Gascard,
1998
.
C. Labat,
A. Serraf,
C. Brink,
1997,
Mediators of inflammation.
S. Dahlén,
L. Walch,
M. Bäck,
2002,
British journal of pharmacology.
L. Walch,
M. Bäck,
C. Brink,
2002,
Acta physiologica Scandinavica.
S. Dahlén,
L. Walch,
M. Bäck,
2000,
European journal of pharmacology.
S. Dahlén,
L. Walch,
M. Bäck,
2000,
European journal of pharmacology.
M. Yeadon,
V. Thomas de Montpréville,
C. Labat,
1999,
The European respiratory journal.
C. Labat,
C. Brink,
X. Norel,
1998,
The Journal of pharmacology and experimental therapeutics.
C. Brink,
X. Norel,
I. Gorenne,
1996,
Trends in pharmacological sciences.
C. Labat,
J. Cortijo,
C. Brink,
1995,
British journal of pharmacology.
C. Brink,
T. Abram,
P. Gardiner,
1994,
Advances in prostaglandin, thromboxane, and leukotriene research.
C. Labat,
J. Benveniste,
C. Brink,
1987,
Fundamental & clinical pharmacology.
J. Michel,
L. Feldman,
H. Hlawaty,
2009,
Arteriosclerosis, thrombosis, and vascular biology.
M. Bäck,
C. Brink,
X. Norel,
2006,
Pulmonary pharmacology & therapeutics.
L. Walch,
C. Labat,
C. Brink,
1997,
Fundamental & clinical pharmacology.
S. Dahlén,
L. Walch,
M. Bäck,
2002,
Advances in experimental medicine and biology.
C. Labat,
C. Brink,
X. Norel,
1995,
British journal of pharmacology.
L. Walch,
C. Brink,
X. Norel,
2000,
British journal of pharmacology.
C. Labat,
C. Brink,
I. Gorenne,
1995,
European journal of pharmacology.
J. Benveniste,
C. Brink,
G. Braunstein,
1988,
British journal of pharmacology.
J. Douglas,
C. Brink,
1987
.
L. Walch,
C. Brink,
X. Norel,
2002,
Advances in experimental medicine and biology.
J. Douglas,
C. Brink,
P. Duncan,
1980,
The Journal of pharmacology and experimental therapeutics.
C. Labat,
J. Benveniste,
C. Brink,
1987,
The Journal of pharmacology and experimental therapeutics.
L. Walch,
C. Labat,
C. Brink,
1999,
British journal of pharmacology.
C. Labat,
J. Benveniste,
C. Brink,
1988,
European journal of pharmacology.
C. Brink,
C. Guillot,
J. Orehek,
1980,
British journal of pharmacology.
C. Labat,
C. Brink,
X. Norel,
1999,
Advances in experimental medicine and biology.
B. Baudet,
C. Brink,
J. Cerrina,
1989,
Journal of applied physiology.
J. Douglas,
C. Brink,
P. Duncan,
1982,
British journal of pharmacology.
J. Douglas,
C. Brink,
P. Duncan,
1981,
Prostaglandins.
C. Labat,
J. Benveniste,
C. Brink,
1989,
Prostaglandins.
C. Labat,
C. Brink,
X. Norel,
1993,
British journal of pharmacology.
L. Walch,
C. Labat,
C. Brink,
1996,
British journal of pharmacology.
V. Thomas de Montpréville,
C. Labat,
J. Bara,
1998,
Mediators of inflammation.
C. Labat,
C. Brink,
X. Norel,
1994,
Mediators of inflammation.
C. Labat,
C. Brink,
G. Braunstein,
1991
.
J. Douglas,
C. Brink,
P. Ridgway,
1977,
The Journal of pharmacology and experimental therapeutics.
J. Douglas,
C. Brink,
P. Ridgway,
1977,
The Journal of pharmacology and experimental therapeutics.
C. Labat,
J. Benveniste,
C. Brink,
1991,
International archives of allergy and applied immunology.
C. Labat,
C. Brink,
I. Gorenne,
1996,
Cell Biology and Toxicology.
C. Labat,
C. Brink,
X. Norel,
1993,
The American review of respiratory disease.
L. Walch,
V. de Montpréville,
C. Brink,
2001,
British journal of pharmacology.
C. Labat,
C. Brink,
X. Norel,
1991,
British journal of pharmacology.
C. Labat,
C. Brink,
X. Norel,
1993
.
M. Matera,
C. Brink,
X. Norel,
1990,
Pharmacological research.
C. Labat,
C. Brink,
X. Norel,
1991,
Advances in prostaglandin, thromboxane, and leukotriene research.
L. Walch,
C. Brink,
X. Norel,
2003,
Advances in experimental medicine and biology.
J. Douglas,
C. Brink,
P. Duncan,
1981,
The Journal of pharmacology and experimental therapeutics.
B. Vargaftig,
C. Labat,
S. Eum,
1999,
British journal of pharmacology.
L. Walch,
C. Brink,
X. Norel,
1997,
British journal of pharmacology.
M. Chignard,
J. Benveniste,
C. Brink,
1983
.
J. Douglas,
C. Brink,
P. Duncan,
1981,
The Journal of pharmacology and experimental therapeutics.
V. de Montpréville,
C. Brink,
X. Norel,
2004,
Prostaglandins & other lipid mediators.
Tachyphylaxis to beta-adrenoceptor agonists in guinea pig airway smooth muscle in vivo and in vitro.
J. Douglas,
C. Brink,
A. Bouhuys,
1977,
European journal of pharmacology.
C. Labat,
C. Brink,
X. Norel,
1992,
The Journal of pharmacology and experimental therapeutics.
Relaxation of isolated human pulmonary muscle preparations with prostacyclin (PGI2) and its analogs.
C. Labat,
J. Benveniste,
C. Brink,
1987,
Prostaglandins.
J. Douglas,
C. Brink,
A. Bouhuys,
1977
.
Jilly F. Evans,
J. Drazen,
S. Dahlén,
2020
.
Jilly F. Evans,
J. Drazen,
S. Dahlén,
2019,
IUPHAR/BPS Guide to Pharmacology CITE.
J. Bara,
C. Brink,
P. Roger,
2001,
The European respiratory journal.
J. Bara,
C. Brink,
P. Roger,
2000,
Therapie.
C. Brink,
P. Roger,
J. Gascard,
1999,
Mediators of inflammation.
Edit Nagy,
Athanase Benetos,
Magnus Bäck,
2013,
Journal of hypertension.
L. Walch,
C. Brink,
X. Norel,
1999,
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
L. Louedec,
C. Brink,
X. Norel,
2008,
Cardiovascular research.
J. Douglas,
C. Brink,
P. Duncan,
1982,
The Journal of pharmacy and pharmacology.
C. Labat,
C. Brink,
X. Norel,
1994,
Life Science.
L. Walch,
C. Labat,
C. Brink,
1998,
Journal of Physiology-Paris.
L. Walch,
C. Labat,
C. Brink,
1999,
British journal of pharmacology.
Y. Bouhnik,
J. Fabiani,
C. Brink,
2012,
Presse medicale.
C. Labat,
J. Benveniste,
C. Brink,
1985,
British Journal of Pharmacology.
J. Drazen,
S. Dahlén,
C. Serhan,
2023
.
C. Labat,
C. Brink,
X. Norel,
1995,
The Journal of pharmacology and experimental therapeutics.
A. Chatonnet,
L. Walch,
C. Brink,
2005,
Life sciences.
M. Yeadon,
C. Labat,
J. Bara,
1999,
The European respiratory journal.
L. Walch,
C. Brink,
X. Norel,
1999,
The´rapie (Paris).
V. Thomas de Montpréville,
C. Labat,
J. Bara,
2022
.
Acetylcholine induces a greater production of prostacyclin in human pulmonary arteries than in veins
L. Walch,
C. Brink,
X. Norel,
1998,
Journal of Physiology-Paris.